The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Routine, prospective DPYD genotyping guided dose-individualisation for patients receiving fluoropyrimidines: Implementation, prevalence and patient safety outcomes from a multi-institutional clinical trial.
 
Mark Nalder
Honoraria - MSD/Merck
 
Tivya Kulasegaran
No Relationships to Disclose
 
Ben Lundie
No Relationships to Disclose
 
Rick Woods
No Relationships to Disclose
 
Melissa A. Eastgate
Honoraria - The Limbic
Consulting or Advisory Role - MSD Oncology
Travel, Accommodations, Expenses - MSD Oncology
 
David Wyld
Consulting or Advisory Role - Ipsen; Novartis; Novartis
Speakers' Bureau - Ipsen
Research Funding - Ipsen (Inst); Ipsen (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - Ipsen; Ipsen; Ipsen; Ipsen; Ipsen; MSD Oncology; Novartis; Novartis; Novartis
 
Matthew E. Burge
Stock and Other Ownership Interests - coclear; CSL Limited; pfizer
Honoraria - AstraZeneca; Bristol Myers squibb; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; merck srpe Dohme; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)